BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12475891)

  • 1. Distinct palindromic extensions of the 5'-TTC...GAA-3' motif allow STAT6 binding in vivo.
    Kraus J; Börner C; Höllt V
    FASEB J; 2003 Feb; 17(2):304-6. PubMed ID: 12475891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT6 transcription factor binding sites with mismatches within the canonical 5'-TTC...GAA-3' motif involved in regulation of delta- and mu-opioid receptors.
    Börner C; Wöltje M; Höllt V; Kraus J
    J Neurochem; 2004 Dec; 91(6):1493-500. PubMed ID: 15584925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
    Friedrich K; Wietek S
    Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of BAZF and Bc16 to STAT6-binding DNA sequences.
    Hartatik T; Okada S; Okabe S; Arima M; Hatano M; Tokuhisa T
    Biochem Biophys Res Commun; 2001 Jun; 284(1):26-32. PubMed ID: 11374866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PU.1 is required for transcriptional activation of the Stat6 response element in the Igepsilon promoter.
    Pesu M; Aittomäki S; Välineva T; Silvennoinen O
    Eur J Immunol; 2003 Jun; 33(6):1727-35. PubMed ID: 12778491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of signal transducers and activators of transcription during human adipogenesis.
    Harp JB; Franklin D; Vanderpuije AA; Gimble JM
    Biochem Biophys Res Commun; 2001 Mar; 281(4):907-12. PubMed ID: 11237746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
    J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.
    Goenka S; Youn J; Dzurek LM; Schindler U; Yu-Lee LY; Boothby M
    J Immunol; 1999 Nov; 163(9):4663-72. PubMed ID: 10528163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
    Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
    J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of STATs in transcriptional control and their impact on cellular function.
    Bromberg J; Darnell JE
    Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells.
    Gupta S; Jiang M; Pernis AB
    J Immunol; 1999 Oct; 163(7):3834-41. PubMed ID: 10490982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model.
    Yokozeki H; Wu MH; Sumi K; Awad S; Satoh T; Katayama I; Takeda K; Akira S; Kaneda Y; Nishioka K
    Gene Ther; 2004 Dec; 11(24):1753-62. PubMed ID: 15306842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of STAT proteins and cytokine genes in human Th1 and Th2 cells generated in the absence of IL-12 and IL-4.
    Moriggl R; Kristofic C; Kinzel B; Volarevic S; Groner B; Brinkmann V
    J Immunol; 1998 Apr; 160(7):3385-92. PubMed ID: 9531298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stat6 inhibits human interleukin-4 promoter activity in T cells.
    Georas SN; Cumberland JE; Burke TF; Chen R; Schindler U; Casolaro V
    Blood; 1998 Dec; 92(12):4529-38. PubMed ID: 9845517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells.
    Yu CR; Young HA; Ortaldo JR
    J Leukoc Biol; 1998 Aug; 64(2):245-58. PubMed ID: 9715265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.
    Liddiard K; Welch JS; Lozach J; Heinz S; Glass CK; Greaves DR
    BMC Mol Biol; 2006 Nov; 7():45. PubMed ID: 17134490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-gamma activation site.
    Karras JG; Wang Z; Coniglio SJ; Frank DA; Rothstein TL
    J Immunol; 1996 Jul; 157(1):39-47. PubMed ID: 8683142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biology of Stat4 and Stat6.
    Wurster AL; Tanaka T; Grusby MJ
    Oncogene; 2000 May; 19(21):2577-84. PubMed ID: 10851056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites.
    Ehret GB; Reichenbach P; Schindler U; Horvath CM; Fritz S; Nabholz M; Bucher P
    J Biol Chem; 2001 Mar; 276(9):6675-88. PubMed ID: 11053426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.